the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Lukanisman: Health clinic construction delayed in Sarawak due to raw material shortage

KUALA LUMPUR: The delay in the construction of several health clinics in Sarawak is due to a shortage of building materials, especially cement, Deputy Health Minister Lukanisman Awang Sauni (pix) said.

He said it was found that projects severely affected by the lack of these supplies were the type-three health clinics and hospital in Lawas, as well as some health clinics in Serian, Tabuan, and Semop.

“There were also delays of materials for industrial building system reaching Sarawak as they are imported and need to go through ports in the peninsula first,“ he said during the special chamber session at the Dewan Rakyat today.

He was replying to a supplementary question from Dr Kelvin Yii Lee Wuen (PH-Bandar Kuching) who asked on the data and reasons for the delay in the construction of several health clinics in Sarawak.

At the same time, Lukanisman said that another contributing factor is the high demand for raw materials after the COVID-19 pandemic.

“After the (COVID-19) pandemic, MOH had been working to meet the clinic completion deadlines and this led to an increase in the demand for raw materials,“ he said.

Meanwhile, in response to Yii’s original question about the development status for the Tabuan Jaya Health Clinic in Kuching, Lukanisman said it was 54.96 per cent complete as of Oct 31. –Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings